Pfizer · NSE: PFIZER · BSE: 500680
Q1 FY20 results · Apr–Jun 2019
Pfizer reported revenue from operations of ₹544.40 crore (up 6.3% from Q1 FY19) and net profit of ₹112.81 crore (up 22.8% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a standalone basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 544.40 | 512.31 | +6.3% | 535.66 | +1.6% |
| Other income | 35.83 | 30.53 | +17.4% | 35.45 | +1.1% |
| Total income | 580.23 | 542.84 | +6.9% | 571.11 | +1.6% |
| Profit before tax | 174.91 | 142.19 | +23.0% | 168.22 | +4.0% |
| Net profit for the period | 112.81 | 91.84 | +22.8% | 109.47 | +3.1% |
| EPS, basic (₹) | 24.66 | 20.07 | +22.9% | 23.93 | +3.1% |
| Net margin (%) | 20.7 | 17.9 | 20.4 |
Standalone
- Filed with BSE
- 09 Aug 2019, 13:22 IST
- Board meeting
- 09 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE